DPHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Jun 2017
| CCM DUOPHARMA BIOTECH BERHAD |
| Financial Year End | 31 Dec 2017 |
| Quarter | 2 Qtr |
| Quarterly report for the financial period ended | 30 Jun 2017 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Jun 2017
|
30 Jun 2016
|
30 Jun 2017
|
30 Jun 2016
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
117,049
|
79,135
|
240,355
|
158,605
|
| 2 | Profit/(loss) before tax |
12,642
|
7,723
|
24,764
|
17,664
|
| 3 | Profit/(loss) for the period |
9,641
|
3,941
|
19,205
|
11,769
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
9,653
|
4,503
|
19,217
|
12,346
|
| 5 | Basic earnings/(loss) per share (Subunit) |
3.46
|
1.41
|
6.88
|
4.22
|
| 6 | Proposed/Declared dividend per share (Subunit) |
2.50
|
2.50
|
2.50
|
2.50
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
1.6600
|
1.6300
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | CCM DUOPHARMA BIOTECH BERHAD |
| Stock Name | CCMDBIO |
| Date Announced | 25 Aug 2017 |
| Category | Financial Results |
| Reference Number | FRA-23082017-00015 |